Amedeo Smart

Free Medical Literature Service

 

Amedeo

Irritable Bowel Syndrome
  Free Subscription

Articles published in
Scand J Gastroenterol
    April 2024
  1. RAUMA J, Jansson S, Cao Y, van Nieuwenhoven MA, et al
    A comparison of Swedish IBS patients and general practitioners regarding viewpoints on IBS: a Q-methodology study.
    Scand J Gastroenterol. 2024 Apr 1:1-7. doi: 10.1080/00365521.2024.2328590.
    >> Share

  2. EL-SALHY M, Gilja OH, Hatlebakk JG
    Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females.
    Scand J Gastroenterol. 2024;59:391-400.
    >> Share

    November 2023
  3. ALIHOSSEINI S, Khodaei F, Jaberinezhad M, Azari M, et al
    Evaluation of gallbladder contractility and Doppler findings in patients with irritable bowel syndrome; a case-control study.
    Scand J Gastroenterol. 2023 Nov 30:1-8. doi: 10.1080/00365521.2023.2287989.
    >> Share

    September 2023
  4. BILLING J, Berentsen B, Lundervold A, Hillestad EMR, et al
    Cognitive function in patients with irritable bowel syndrome: impairment is common and only weakly correlated with depression/anxiety and severity of gastrointestinal symptoms.
    Scand J Gastroenterol. 2023 Sep 20:1-9. doi: 10.1080/00365521.2023.2256916.
    >> Share

    August 2023
  5. SJODAHL J, Ingemansson A, Bureychak T, Norlin AK, et al
    Defecation symptoms in primary health care patients with irritable bowel syndrome.
    Scand J Gastroenterol. 2023 Aug 23:1-9. doi: 10.1080/00365521.2023.2248538.
    >> Share

    June 2023
  6. DALE HF, Lorentzen SCS, Mellin-Olsen T, Valeur J, et al
    Diet-microbiota interaction in irritable bowel syndrome: looking beyond the low-FODMAP approach.
    Scand J Gastroenterol. 2023 Jun 29:1-12. doi: 10.1080/00365521.2023.2228955.
    >> Share

    February 2023
  7. STEINSVIK EK, Hausken T, Fluge O, Mella O, et al
    Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.
    Scand J Gastroenterol. 2023 Feb 2:1-8. doi: 10.1080/00365521.2023.2173533.
    >> Share

  8. TORNKVIST NT, Backman AS, Linder M, Altman M, et al
    Identification of irritable bowel syndrome in the Swedish National Patient Register: a validation study.
    Scand J Gastroenterol. 2023 Feb 1:1-9. doi: 10.1080/00365521.2023.2173021.
    >> Share

    October 2022
  9. HONG G, Li Y, Yang M, Li G, et al
    Baseline gut microbial profiles are associated with the efficacy of Bacillus subtilis and Enterococcus faecium in IBS-D.
    Scand J Gastroenterol. 2022 Oct 25:1-10. doi: 10.1080/00365521.2022.2136013.
    >> Share

    August 2022
  10. YAN X, Wang J, Bai Y
    Potentials of circSOBP in the diagnosis and prognosis of gastric cancer.
    Scand J Gastroenterol. 2022 Aug 20:1-5. doi: 10.1080/00365521.2022.2088246.
    >> Share

    April 2022
  11. EL-SALHY M, Mazzawi T, Hausken T, Hatlebakk JG, et al
    The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
    Scand J Gastroenterol. 2022 Apr 29:1-10. doi: 10.1080/00365521.2022.2064725.
    >> Share

  12. HEDSTROM A, Kvarnstrom M, Lindberg G, Alsabeah S, et al
    High prevalence of gastrointestinal symptoms in patients with primary Sjogren's syndrome cannot be attributed to pancreatic exocrine insufficiency.
    Scand J Gastroenterol. 2022 Apr 24:1-7. doi: 10.1080/00365521.2022.2065888.
    >> Share

    March 2022
  13. WALLEN H, Ljotsson B, Svanborg C, Rydh S, et al
    Exposure based cognitive behavioral group therapy for IBS at a gastroenterological clinic - a clinical effectiveness study.
    Scand J Gastroenterol. 2022 Mar 9:1-8. doi: 10.1080/00365521.2022.2047220.
    >> Share

  14. TOUNY AA, Kenny E, Mansson M, Webb DL, et al
    Pain relief and pain intensity response to GLP-1 receptor agonist ROSE-010 in irritable bowel syndrome; clinical study cross-analysis with respect to patient characteristics.
    Scand J Gastroenterol. 2022 Mar 2:1-9. doi: 10.1080/00365521.2022.2041084.
    >> Share

    February 2022
  15. MAZZAWI T, Hausken T, El-Salhy M
    Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation.
    Scand J Gastroenterol. 2022 Feb 14:1-5. doi: 10.1080/00365521.2022.2036809.
    >> Share

  16. JOHANSEN SG, Ness-Jensen E
    The changes in prevalence and risk of irritable bowel syndrome over time in a population-based cohort, the HUNT study, Norway.
    Scand J Gastroenterol. 2022 Feb 4:1-7. doi: 10.1080/00365521.2022.2028005.
    >> Share

  17. RUDERSTAM H, Ohlsson B
    Self-reported IBS and gastrointestinal symptoms in the general population are associated with asthma, drug consumption and a family history of gastrointestinal diseases.
    Scand J Gastroenterol. 2022 Feb 1:1-11. doi: 10.1080/00365521.2022.2031281.
    >> Share

    September 2021
  18. THOMAZ DE ALMEIDA CN, Tahan S, Areco KN, Morais MB, et al
    Association between abuse and neglect with functional constipation and irritable bowel syndrome in adolescents.
    Scand J Gastroenterol. 2021 Sep 1:1-6. doi: 10.1080/00365521.2021.1923059.
    >> Share

    May 2021
  19. VAN MEGEN F, Skodje GI, Stendahl M, Veierod MB, et al
    High disease burden in treated celiac patients - a web-based survey.
    Scand J Gastroenterol. 2021 May 30:1-7. doi: 10.1080/00365521.2021.1930146.
    >> Share

  20. MADSEN AMA, Halkjaer SI, Christensen AH, Gunther S, et al
    The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study.
    Scand J Gastroenterol. 2021 May 17:1-9. doi: 10.1080/00365521.2021.1915375.
    >> Share

    February 2021
  21. MEIRA DE-FARIA F, Bednarska O, Strom M, Soderholm JD, et al
    Colonic paracellular permeability and circulating zonulin-related proteins.
    Scand J Gastroenterol. 2021 Feb 3:1-8. doi: 10.1080/00365521.2021.1879247.
    >> Share

    June 2020
  22. CHI Y, Li C, Wu LH, Wang HH, et al
    The relationship between dectin-1 and mast cells in patients with diarrhea-predominant irritable bowel syndrome.
    Scand J Gastroenterol. 2020 Jun 4:1-7. doi: 10.1080/00365521.2020.1774925.
    >> Share

    May 2020
  23. MOHAMMADIAN G, Dlugosz A, Shetye J, Lindberg G, et al
    Quantification of mucosal EEC in jejunum. A comparative study of IBS patients and healthy controls.
    Scand J Gastroenterol. 2020 May 22:1-6. doi: 10.1080/00365521.2020.1764615.
    >> Share

  24. KOTANI S, Fukuba N, Kawashima K, Mishima Y, et al
    Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
    Scand J Gastroenterol. 2020 May 15:1-5. doi: 10.1080/00365521.2020.1761998.
    >> Share

    April 2020
  25. BERG LK, Goll R, Fagerli E, Ludviksen JK, et al
    Intestinal inflammatory profile shows increase in a diversity of biomarkers in irritable bowel syndrome.
    Scand J Gastroenterol. 2020 Apr 24:1-6. doi: 10.1080/00365521.2020.1754455.
    >> Share

  26. VON VOLKMANN HL, Bronstad I, Tronstad RR, Dizdar V, et al
    Plasma levels of guanylins are reduced in patients with Crohn's disease.
    Scand J Gastroenterol. 2020 Apr 20:1-5. doi: 10.1080/00365521.2020.1748224.
    >> Share

    December 2019
  27. WANG B, Zhao W, Zhao C, Jin H, et al
    What impact do Rome IV criteria have on patients with IBS in China?
    Scand J Gastroenterol. 2019 Dec 12:1-8. doi: 10.1080/00365521.2019.1698650.
    >> Share

  28. HAMREFORS V, Fedorowski A, Ohlsson B
    Susceptibility to diarrhea is related to hemodynamic markers of sympathetic activation in the general population.
    Scand J Gastroenterol. 2019 Dec 2:1-7. doi: 10.1080/00365521.2019.1697742.
    >> Share

    November 2019
  29. WU KQ, Sun WJ, Li N, Chen YQ, et al
    Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance.
    Scand J Gastroenterol. 2019 Nov 25:1-7. doi: 10.1080/00365521.2019.1694067.
    >> Share

  30. WILDER-SMITH CH, Drewes AM, Materna A, Olesen SS, et al
    Symptoms of mast cell activation syndrome in functional gastrointestinal disorders.
    Scand J Gastroenterol. 2019 Nov 5:1-4. doi: 10.1080/00365521.2019.1686059.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016